Arcus Biosciences Inc (RCUS)

NYSE · Biotechnology

29.35
-0.21 (-0.71%)
Updated Aug 18, 3:33 PM ET
AI Rating
Buy
Overall Score
73
Trend
72
Momentum
80
Risk
64

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Feb 19, 2026 120 sessions Aug 14, 2026

AI Analysis

Arcus Biosciences Inc is trading at $29.35, down 0.71% on the session. The 50 day average sits at $27.41 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 57.4, which reads as strong, and MACD is bullish crossover. Volume is average.

The nearest support is around $28.78 with resistance near $31.09, so that band frames the current range. Average daily movement is roughly $1.44, or about 4.9% of the share price, which is what any stop placement has to allow for. The overall health score of 73 out of 100 combines a trend score of 72, momentum of 80 and a risk score of 64.

Technical indicators

RSI (14)
57.4
strong
MACD
0.350
bullish crossover
SMA 20
28.19
SMA 50
27.41
SMA 200
--
unknown
ATR (14)
1.44
avg daily range
Support
28.78
Resistance
31.09
Volume vs 20d
1.06x
average
Volatility
51.6%
annualised
1 month
+5.02%
3 months
+18.58%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.